english Icono del idioma   español Icono del idioma  

Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/20.500.12008/11097 Cómo citar
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorCarreón Burciaga, Ramón Giles
dc.contributor.authorGonzález González, Rogelioes
dc.contributor.authorMolina Frechero, Nellyes
dc.contributor.authorBologna-Molina, Ronelles
dc.date.accessioned2018-03-06T20:31:52Z-
dc.date.available2018-03-06T20:31:52Z-
dc.date.issued2015es
dc.date.submitted20180305es
dc.identifier.citationCarreón Burciaga, R., González-González, R., Molina-Frechero, N. y otros. "Immunoexpression of Ki-67, MCM2, and MCM3 in ameloblastoma and ameloblastic carcinoma and their correlations with clinical and histopathological patterns". Disease markers [en linea]. 2015, Vol. 2015, pp. 1-8es
dc.identifier.urihttp://hdl.handle.net/20.500.12008/11097-
dc.description.abstractCell proliferation assays are performed using antibodies against nuclear proteins associated with DNA replication. These nuclear proteins have gained special interest to predict the biological and clinical behaviors of various tumors. The aim of this study was to analyze the presence of Ki-67 protein and the minichromosome maintenance-2 (MCM2) and maintenance-3 (MCM3) proteins in ameloblastoma. Materials and Methods. Cell proliferation marker expression levels were assessed via immunohistochemistry in 111 ameloblastoma cases (72 unicystic ameloblastoma samples, 38 solid/multicystic ameloblastoma samples, and 1 ameloblastic carcinoma). The label index was performed as described previously. Results. MCM2 and MCM3 showed higher proliferation indexes in all variants of ameloblastoma compared to the classic marker Ki-67. No correlation between the proliferation index and the clinical and protein expression data was observed. Conclusion. The results suggest that clinical features do not directly affect tumor cell proliferation. Moreover, the high levels of cellular proliferation of MCM2 and MCM3 compared with Ki-67 may indicate that MCM2 and MCM3 are more sensitive markers for predicting the growth rate and eventually might be helpful as a tool for predicting aggressive and recurrent behaviors in these tumorses
dc.format.mimetypeapplication/pdfes
dc.languageenes
dc.publisherHindawi Publishing Corporationes
dc.relation.ispartofDisease markers, Vol. 2015, pp. 1-8es
dc.rightsLas obras depositadas en el Repositorio se rigen por la Ordenanza de los Derechos de la Propiedad Intelectual de la Universidad De La República. (Res. Nº 91 de C.D.C. de 8/III/1994 – D.O. 7/IV/1994) y por la Ordenanza del Repositorio Abierto de la Universidad de la República (Res. Nº 16 de C.D.C. de 07/10/2014)es
dc.titleImmunoexpression of Ki-67, MCM2, and MCM3 in ameloblastoma and ameloblastic carcinoma and their correlations with clinical and histopathological patternses
dc.typeArtículoes
dc.rights.licenceLicencia Creative Common Atribución (CC-BY)es
Aparece en las colecciones: Artículos y capítulos de libros - Facultad de Odontología

Ficheros en este ítem:
Fichero Descripción Tamaño Formato   
Bologna_2015_DiseaseMakers.pdf3,78 MBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons